Taglich Brothers
Founded in 1991 and headquartered in Huntington, New York, Taglich Brothers, Inc. is a full-service brokerage and investment banking firm that specializes in the microcap segment of publicly traded securities, focusing on companies with less than $250 million in stock outstanding. The firm targets this niche market due to its historical outperformance compared to larger market segments and the lack of attention from major financial institutions. Taglich Brothers offers a range of services, including private placements of equity and debt, capital formation, restructuring, and recapitalization. Additionally, the firm provides asset management for individual investors across various investment vehicles, such as cash accounts, margin accounts, and retirement accounts. Through its focused approach and expertise, Taglich Brothers aims to capitalize on the inefficiencies present in the microcap market.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
2 past transactions
BioVentrix
Series A in 2023
BioVentrix, Inc. is a medical device company based in San Ramon, California, that specializes in innovative treatments for congestive heart failure (CHF), particularly in patients with ischemic cardiomyopathy. Founded in 2003, the company has developed the Revivent Myocardial Anchoring System, which utilizes a hybrid closed-chest transcatheter procedure to enhance cardiac function. This device operates by restoring the size and volume of the left ventricle through the implantation of micro-anchoring pairs that effectively exclude scarred myocardium from healthy tissue. BioVentrix aims to provide less invasive, catheter-based solutions to improve patient outcomes and slow the progression of CHF, addressing a critical need in cardiac care.
Andera Partners
Series A in 2023
Andera Partners is a Paris-based private equity firm founded in 2001 that invests in unlisted companies in France and internationally. The firm focuses on growth-stage opportunities, primarily through buyouts, and manages over €2 billion in investments across life sciences, growth capital, and sponsorless mezzanine debt. It targets sectors including sustainable energy, transportation and logistics, agribusiness, business-to-business and business-to-consumer, building and construction, cosmetics, distribution, industry, information technology and software, media, medical technology, real estate, therapeutic products, and tourism.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.